Literature DB >> 7543080

Characterization of cell lines established from human hepatocellular carcinoma.

J G Park1, J H Lee, M S Kang, K J Park, Y M Jeon, H J Lee, H S Kwon, H S Park, K S Yeo, K U Lee.   

Abstract

We characterized 8 human hepatocellular-carcinoma cell lines established from the primary tumors of Korean patients. All lines showed substrate adherence and one line from anaplastic tumor also grew as floating aggregates. Most cultured cells maintained many morphological characteristics of the original tumors from which they were derived. Doubling times varied from 34 to 72 hr. All lines showed relatively high viability and were not contaminated with Mycoplasma or bacteria. All lines showed aneuploidy and were proven to be unique by DNA fingerprinting analysis. Hepatitis-B-virus (HBV) DNA was integrated in the genomes of all lines. Two of the cell lines (SNU-354, SNU-368) showed expression of HBV and HBVx (HBx) transcripts. SNU-354 strongly expressed albumin, and SNU-368 expressed transferrin and insulin-like growth factor II. No lines produced alpha-fetoprotein at the RNA and protein level. These cell lines represent useful tools for in vitro studies related to hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543080     DOI: 10.1002/ijc.2910620308

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

1.  Establishment and characterization of nine human brain tumor cell lines.

Authors:  K H Shin; G Choe; Y J Park; J H Jang; H W Jung; J G Park
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

2.  Rapid authentication of animal cell lines using pyrolysis mass spectrometry and auto-associative artificial neural networks.

Authors:  R Goodacre; D J Rischert; P M Evans; D B Kell
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines.

Authors:  Tae-Jin Song; David P Eisenberg; Prasad S Adusumilli; Michael Hezel; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

Review 4.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

5.  B-lymphoblastoid cell lines from cancer patients.

Authors:  W K Lee; S M Kim; Y S Sim; S G Cho; S H Park; C W Kim; J G Park
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

6.  Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway.

Authors:  Geum-Youn Gwak; Tae Gun Moon; Dong Ho Lee; Byung Chul Yoo
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

7.  Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Sung-Hee Lee; Soo-Mi Lee; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

8.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

9.  Decreased mitochondrial OGG1 expression is linked to mitochondrial defects and delayed hepatoma cell growth.

Authors:  Young-Kyoung Lee; Hwang-Guem Youn; Hee-Jung Wang; Gyesoon Yoon
Journal:  Mol Cells       Date:  2013-05-14       Impact factor: 5.034

10.  Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition.

Authors:  Yoav D Shaul; Elizaveta Freinkman; William C Comb; Jason R Cantor; Wai Leong Tam; Prathapan Thiru; Dohoon Kim; Naama Kanarek; Michael E Pacold; Walter W Chen; Brian Bierie; Richard Possemato; Ferenc Reinhardt; Robert A Weinberg; Michael B Yaffe; David M Sabatini
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.